Arcus Biosciences, Inc. (RCUS)
23.83
+0.60
(+2.58%)
USD |
NYSE |
Dec 31, 16:00
23.86
+0.03
(+0.13%)
After-Hours: 20:00
Arcus Biosciences Research and Development Expense (Quarterly): 141.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.334B |
| Actinium Pharmaceuticals, Inc. | 4.042M |
| Madrigal Pharmaceuticals, Inc. | 173.65M |
| Karyopharm Therapeutics, Inc. | 30.42M |
| Janux Therapeutics, Inc. | 34.63M |